Edesa Biotech, Inc. (EDSA) Financials

EDSA Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 12.7 million 3.9 million
March 31, 2026 12.4 million 2.2 million
Dec. 31, 2025 14.7 million 756163
Sept. 30, 2025 13.7 million 1.2 million

EDSA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -3.0 million -147836
March 31, 2026 -2.1 million 66653
Dec. 31, 2025 -2.1 million 81183
Sept. 30, 2025 -1.8 million 404425

EDSA Net Income

No data available :(

EDSA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 10.3 million - -
March 31, 2026 10.0 million - -
Dec. 31, 2025 12.1 million - -
Sept. 30, 2025 10.8 million - -

EDSA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 9.0 million
March 31, 2026 8.3 million
Dec. 31, 2025 8.0 million
Sept. 30, 2025 7.1 million

EDSA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 7 4.0 million 1.6 million -
March 31, 2026 3 2.8 million 1.5 million -
Dec. 31, 2025 4 1.1 million 1.2 million -
Sept. 30, 2025 3 1.2 million 1.2 million -

EDSA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - 25644
March 31, 2026 50918 25872
Dec. 31, 2025 - 25459
Sept. 30, 2025 - 25868

EDSA Revenue by Segment
Graph available only for paid members. Upgrade to see it.

EDSA

Price: $3.86

52 week price:
0.72
20.32

Earnings Per Share: -1.42 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: Canada

Volume: 79700

Market Capitalization: 45.6 million

Links: